The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Follow the instructions!

Journal: Non Nocere. New Therapeutic Journal. 2025;(7): 96‑100

Read: 463 times

To cite this article:

Follow the instructions! Non Nocere. New Therapeutic Journal. 2025;(7):96‑100. (In Russ.)

References:

  1. Kairys N, Carlson K, Garg M. Bacterial Vaginosis. 2024 May 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. https://www.ncbi.nlm.nih.gov/books/NBK459216/
  2. Ministry of Health of the Russian Federation. Clinical recommendations. Bacterial vaginosis. ID: 206_2. Year of approval: 2022. Date of access: 06/21/2025. https://cr.minzdrav.gov.ru/viewcr/206_2
  3. Farr A, Swidsinski S, Surbek D, et al. Bacterial Vaginosis: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/028, June 2023). Geburtshilfe Frauenheilkd. 2023 Nov 3;83(11):1331-1349. https://doi.org/10.1055/a2169-8539
  4. Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it’s associated resistance patterns. Microb Pathog. 2019 Feb;127:21-30.  https://doi.org/10.1016/j.micpath.2018.11.046
  5. Coughlin G, Secor M. Bacterial vaginosis: update on evidence-based care. Adv Nurse Pract. 2010 Jan;18(1):41-4, 53. 
  6. Russo R, Karadja E, De Seta F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef Microbes. 2019 Feb 8;10(1):19-26.  https://doi.org/10.3920/BM2018.0075
  7. Machado A, Cerca N. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis. J Infect Dis. 2015 Dec 15;212(12):1856-1861. https://doi.org/10.1093/infdis/jiv338
  8. Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.  https://doi.org/10.1016/j.ajog.2018.11.1089
  9. Baruah FK, Sharma A, Das C, Hazarika NK, Hussain JH. Role of Gardnerella vaginalis as an etiological agent of bacterial vaginosis. Iran J Microbiol. 2014 Dec;6(6):409-414. 
  10. Verstraelen H, Verhelst R. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect Ther. 2009 Nov;7(9):1109-1124. https://doi.org/10.1586/eri.09.87
  11. Plummer EL, Vodstrcil LA, Doyle M, et al. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis. mBio. 2021 Oct 26;12(5):e0232321. https://doi.org/0.1128/mBio.02323-21
  12. Coudray MS, Madhivanan P. Bacterial vaginosis – A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:143-148.  https://doi.org/10.1016/j.ejogrb.2019
  13. Menard JP. Antibacterial treatment of bacterial vaginosis: current and emerging therapies. Int J Womens Health. 2011;3:295-305.  https://doi.org/10.2147/IJWH.S23814
  14. Peixoto F, Camargos A, Duarte G, Linhares I, Bahamondes L, Petracco A. Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis. Int J Gynaecol Obstet. 2008 Sep;102(3):287-292.  https://doi.org/10.1016/j.ijgo.2008.04.014
  15. Govender L, Hoosen AA, Moodley J, Moodley P, Sturm AW. Bacterial vaginosis and associated infections in pregnancy. Int J Gynaecol Obstet. 1996 Oct;55(1):23-28.  https://doi.org/10.1016/0020-7292(96)02744-0
  16. Redondo-Lopez V, Meriwether C, Schmitt C, Opitz M, Cook R, Sobel JD. Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis. 1990 Jan–Mar;17(1):51-53. 
  17. Redelinghuys MJ, Ehlers MM, Dreyer AW, Kock MM. Normal flora and bacterial vaginosis in pregnancy: an overview. Crit Rev Microbiol. 2016 May;42(3):352-363.  https://doi.org/10.3109/1040841X.2014.954522
  18. Ozyurt E, Toykuliyeva MB, Danilyans IL, Morton O, Baktir G. Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran) – a triple-active pessary for the treatment of single and mixed vaginal infections. Int J Gynaecol Obstet. 2001 Jul;74(1):35-43.  https://doi.org/10.1016/s0020-7292(01)00388-5
  19. Dobrokhotova Yu.E., Kazantseva V.D., Bondarenko K.R. Bacterial vaginosis: modern anti-relapse treatment tactics. RMJ. 2022;8:61-65. 
  20. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.  https://doi.org/10.15585/mmwr.rr7004a1
  21. Abd El Aziz MA, Sharifipour F, Abedi P, Jahanfar S, Judge HM. Secnidazole for treatment of bacterial vaginosis: a systematic review. BMC Womens Health. 2019 Oct 21;19(1):121.  https://doi.org/10.1186/s12905-019-0822-2
  22. Bohbot JM, Vicaut E, Fagnen D, Brauman M. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole. Infect Dis Obstet Gynecol. 2010;2010:705692. https://doi.org/10.1155/2010/705692
  23. Dobrokhotova Yu.E., Shadrova P.A. Therapeutic capabilities of secnidazole in the treatment of bacterial vaginosis. Russian Journal of Woman and Child Health. 2022;5(4):297-302 (in Russ.) https://doi.org/10.32364/2618-8430-2022-5-4-297-302
  24. Kukes I.V., Detusheva E.V. Assessment of the pharmacodynamic parameters of secnidazole in the context of overcoming the protective biofilms of bacterial agents using an in vitro model as an example. Drugs and Rational Pharmacotherapy. 2024; 2(11): 37-44.  https://doi.org/10.56356/27827259_2024_11_37
  25. Bezhena VF, Molchanov OL, Lazareva NB, Galiullina LA, Poznyak AL. Efficacy of secnidazole in the treatment of trichomoniasis and vaginal dysbiosis. Meditsinskiy sovet = Medical Council. 2022;(5):144-151. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-5-144-151
  26. Kutsenko I.G., Borovikov I.O., Kravtsova E.I. et al. Bacterial vaginosis: comparative effectiveness of treatments with 5-nitroimidazole derivatives. Russian Journal of Woman and Child Health. 2023;6(2):78-87 (in Russ.) https://doi.org/10.32364/2618-8430-2023-6-2-78-87
  27. Russian State Register of Medicines. Medications. Limenda. LP-No. (007772)-(RG-RU) dated 11/21/2024. Instructions for use.  https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=bc902c72-6329-4076-88ce67ca61058843
  28. Russian State Register of Medicines. Medications. A secret. LP 003863-030921 dated 09/03/2021. Instructions for use.  https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=99fcea94-475b-45c4-a93b-f82bc086abf6

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.